Aardvark Therapeutics (NASDAQ: AARD)
$10.78
(-4.3%)
-$0.48
Price as of August 15, 2025, 4:00 p.m. ET
Aardvark Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Aardvark Therapeutics Company Info
Aardvark Therapeutics specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders. Aardvark Therapeutics was founded by Tien Lee in 2017.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.